Loss-of-function mutations in one allele of SLC12A5, encoding KCC2, produce a severe infantile-onset pharmaco-resistant epilepsy syndrome, epilepsy of infancy with migrating focal seizures (EIMFS) [51,52]. This evidence concerns the gene SLC12A5 and epilepsy of infancy with migrating focal seizures.